Researchers at University of California San Diego School of Medicine have been selected to lead components of the NIH Common Fund’s Bridge to Artificial Intelligence program.
Technological innovations are often hailed as transformative tools capable of revolutionizing healthcare. From gene editing for conditions like sickle cell disease to AI predicting hospital readmissions, to telemedicine expanding healthcare access, these advancements have the potential to change the way we treat diseases.
